Product Name :
Human LILRB4 Protein
EN
HM18; ILT3; ILT-3; LILRB4; LIR5; CD85K
Description:
| Human LILRB4/CD85k/ILT3 Protein with the C-hFc Tag |Source: The reco|>95% by SEC-HPLC and SDS-|Less than 1 EU per ug of protein as determined by LAL method. |Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |Reconstitution: It is recommended to reconstitute the lyophilized reco|The reco|The reco|>95% by SEC-HPLC and SDS-|Less than 1 EU per ug of protein as determined by LAL method. |Formulation: Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |Reconstitution: It is recommended to reconstitute the lyophilized reco|The recombinant Human LILRB4/CD85k/ILT3 Protein is shipped with ice |Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 week, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution.
Source:
The recombinant Human LILRB4/CD85k/ILT3 Protein, (amino acids Gln22-Arg256) fused with a hFc tag at the C-terminus, was produced in HEK 293 cells.
Molecular Weight :
The recombinant Human LILRB4/CD85k/ILT3 protein with the hFc tag at the C-terminus has a predicted MW of 52.6 kDa. Due to glycosylation, the protein migrates to 60-68 kDa based on Tris-Bis PAGE result.
Activity:
Immobilized recombinant Human LILRB4 protein with the C-hFc tag at 0.2 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Biotinylated Anti-LILRB4 Antibody protein with the C-hFc tag with the EC50 of 16.1 ng/ml determined by ELISA (QC Test). The affinity constant of 74.20 nM as determined in SPR assay (Biacore T200).
Purity :
>95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin:
LevelLess than 1 EU per ug of protein as determined by LAL method.
Formulation :
Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution:
It is recommended to reconstitute the lyophilized recombinant Human LILRB4/CD85k/ILT3 Protein in sterile H2O to a protein concentration not less than 100 ug/ml. Centrifuge the tube before opening. BP005510Human LILRB4/CD85k/ILT3 Protein with the C-His-Avi Tag SourceThe recombinant Human LILRB4/CD85k/ILT3 Protein, (amino acids Gln22-His257) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Shipping:
The recombinant Human LILRB4/CD85k/ILT3 Protein is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage :
/strong>Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Related category websites: https://www.medchemexpress.com/recombinant-proteins.html
Popular product recommendations:
Zika virus E/Envelope Proteinmedchemexpress
Inhibin alpha chain/INHAStorage & Stability
Popular categories:
Insulin-like Growth Factor 1 Receptor (IGF-I R)
Ig-alpha/CD79a